E-course: Overtreatment and oversurveillance for low grade NMIBC. Strategies for de-intensification: Ready for prime time?
In this e-course, we will dive into the critical nuances surrounding the management of low-grade non-muscle-invasive bladder cancer (NMIBC), a condition where the balance between aggressive treatment and vigilant surveillance is paramount.
Despite being characterised by a generally favourable prognosis, low-grade NMIBC poses significant challenges due to the potential for overtreatment and oversurveillance.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
Our expert panel will explore the complexities of this delicate balance, addressing the implications of unnecessary interventions such as overzealous surgical procedures and excessive surveillance protocols.
Throughout the e-course, we will navigate the evolving landscape of NMIBC management, highlighting evidence-based strategies to optimise patient outcomes while minimising the risks of overtreatment-related morbidity and healthcare burden.
From the integration of novel diagnostic technologies to the refinement of risk stratification algorithms, our discussions aim to empower clinicians with practical insights for delivering personalised and judicious care to patients with low-grade NMIBC.
Join us as we engage in insightful conversations, share best practices, and collaborate towards enhancing the quality of care for individuals grappling with low-grade NMIBC.
Speakers:
- Prof. M. Rouprêt (FR)
- Dr. B. Pradere (FR)
- Prof. Dr. J.A. Witjes (NL)
This e-course is brought to you in collaboration with ESOU.